ID: ALA136848

Max Phase: Preclinical

Molecular Formula: C16H21N3O5S

Molecular Weight: 195.22

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  Cc1ccc(S(=O)(=O)O)cc1.Nc1ccccc1NC[C@H](N)C(=O)O

Standard InChI:  InChI=1S/C9H13N3O2.C7H8O3S/c10-6-3-1-2-4-8(6)12-5-7(11)9(13)14;1-6-2-4-7(5-3-6)11(8,9)10/h1-4,7,12H,5,10-11H2,(H,13,14);2-5H,1H3,(H,8,9,10)/t7-;/m0./s1

Standard InChI Key:  WJPVCFYVFTWZQP-FJXQXJEOSA-N

Associated Targets(non-human)

Glutamate receptor ionotropic, kainate 722 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Glutamate receptor ionotropic, AMPA 2103 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 195.22Molecular Weight (Monoisotopic): 195.1008AlogP: 0.09#Rotatable Bonds: 4
Polar Surface Area: 101.37Molecular Species: ZWITTERIONHBA: 4HBD: 4
#RO5 Violations: 0HBA (Lipinski): 5HBD (Lipinski): 6#RO5 Violations (Lipinski): 1
CX Acidic pKa: 2.54CX Basic pKa: 9.11CX LogP: -2.75CX LogD: -2.76
Aromatic Rings: 1Heavy Atoms: 14QED Weighted: 0.51Np Likeness Score: 0.02

References

1. Sun G, Uretsky NJ, Wallace LJ, Shams G, Weinstein DM, Miller DD..  (1996)  Synthesis of chiral 1-(2'-amino-2'-carboxyethyl)-1,4-dihydro-6,7-quinoxaline-2,3-diones: alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionate receptor agonists and antagonists.,  39  (22): [PMID:8893837] [10.1021/jm950632+]

Source